At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Papix acne scardevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Open Label, Uncontrolled Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar in the Prevention and Improvement of Scars and Lesions Associated With Acne
In Brief
A clinical study evaluating Papix acne scar for Acne and Scars. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The scope of this open label clinical trial is to evaluate and confirm the performance of Papix acne scar in the prevention and improvement of acne scars in subject suffering for mild to moderate acne. The product will be applied for 8 consecutive weeks and 3 clinical follow up visits will be performed.
Study Details
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartSep 2020
First PostedMar 2021
Primary CompletionJul 2021
TodayJul 2026
First PostedMar 19, 2021
Enrollment StartSep 25, 2020
Primary CompletionJul 1, 2021
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.3 years ago
Interventions
Papix acne scardevice
PapiX acne scar, class IIa medical device, gel for acne scar. to be applied 2 times per day during the 8 weeks of study duration